Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Biogen

Humana

Universal Health Services

As the Covid-19 vaccines from Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) continue to be distributed throughout the U.S. and internationally to doctors, nurses, the elderly and other vulnerable populations, investors are looking to the health care industry to find value.

4 Health Care Stocks to Consider as Covid-19 Vaccine Distribution Continues

Anthem

Cigna

Centene

UnitedHealth Group

Shares of managed-care companies were falling, but analysts say a Democratic win in the Georgia races could mean better funding for health care, and a beefing up of the Affordable Care Act.

Democratic Control of the Senate Is Actually Good for Health Insurance Stocks, Analysts Say

Shares of CVS Health Corp. were down 1.0% in premarket trading on Wednesday after the drugstore chain said it plans to give the first dose of COVID-19 vaccines in roughly 8,000 skilled-nursing facilities in 49 states by Jan. 25. The program allows both residents and employees of the facilities to get one of the two authorized COVID-19 vaccines right now; both groups are considered by the U.S. government to be at high risk of contracting the coronavirus.

CVS projects first round of vaccine doses in skilled nursing homes to be completed by Jan. 25

CVS Health said it expects to complete the first round of Covid vaccinations in nursing homes by Jan. 25, on track to meet its original goal. The company said it has confronted a couple of challenges during the program, including lower-than-expected uptake in staff.

CVS says it expects to finish first round of Covid vaccines in nursing homes by Jan. 25

WOONSOCKET, R.I., Jan. 6, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) is now administering COVID-19 vaccines in skilled nursing facilities in 49 states, with the rollout beginning in 36 states and Washington, D.C. last week. Start dates were as follows: December 21: Connecticut, Florida,...

CVS Health Provides Update on COVID-19 Vaccinations in Long-Term Care Facilities

CVS Health is on schedule to deliver the first round of dosages to long-term care facilities in 49 states by Jan. 25.

CVS: Vaccinations In Long-Term Care Facilities On Track In 49 States

CVS Health's near 3% yield remains well covered, with a YTD adjusted EPS payout ratio of 24.2% and a YTD FCF payout ratio of 18.7%. CVS Health has delivered 4.9% YoY total revenue growth through the first 9 months of this fiscal year while the company has posted impressive 16.1% YoY growth in adjusted EPS.

CVS Health Continues To Deliver Solid Operating Results

Charles Schwab

MADISON HEIGHTS, Mich., Dec. 31, 2020 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced CVS Health Corp. (NYSE: CVS) as its "Stock to Study" and Charles Schwab Corp. (NYSE: SCHW) its "Undervalued Stock" in the March 2021...

BetterInvesting™ Magazine Chooses CVS Health Corp. As "Growth" Stock and Charles Schwab Corp. As "Undervalued" For March 2021 Issue

Colgate-Palmolive

GlaxoSmithKline

Henry Schein

Johnson & Johnson

Procter & Gamble

DENTSPLY SIRONA

As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.

8 Dental Stocks If You Want to Clean Up

Beazer Homes USA

iShares MSCI United Kingdom ETF

Lemonade

Stryker

Whirlpool

Investors like keeping an eye on the famed investor Buffett. Here are seven more companies that could possibly become Warren Buffett stocks.

7 Stocks Warren Buffett Should Consider

This article is an update to my September 2019 analysis.The overarching investment thesis remains intact.

CVS Health: A Solid, Long-Term Health Care Stock

Intuitive Surgical

Visa

If you want to avoid being whipsawed by a volatile market, buy time-tested, high-quality companies.

Got $3,000? 3 of the Safest Stocks to Buy for 2021

AbbVie

Conagra Brands

Hershey

Kimberly-Clark

Kroger

Lowe's

Realty Income Corp

Snap-on

Southern Company

Verizon

Like many conservative investors I prefer to put my fixed income into a 5 year CD ladder but this year's near 0% rates have changed my strategy. Since May I have built a portfolio of defensive dividend stocks intended to replace a 5 year CD I couldn't face rolling over at today's 1.30% rate.

I Replaced A Jumbo CD With This Eclectic Portfolio Of Value-Conscious Dividend-Paying Stocks

WOONSOCKET, R.I., Dec. 29, 2020 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that President and Chief Executive Officer Larry Merlo, Executive Vice President and Chief Financial Officer Eva Boratto, and Executive Vice President and President, Aetna Karen Lynch, who...

CVS Health to Present at the 39th Annual J.P. Morgan Healthcare Conference

CVS Health's (CVS) Health Care Benefits arm benefits from strong Medicare annual enrollment period.

CVS Health's (CVS) Front Store Sales Robust, LTC Suffers

Pharmacy giant CVS Health Corporation (NYSE:CVS) is the biggest market-cap healthcare company in America.

CVS Stock Fundamentals at Conflict With Recent Chart Performance

Teladoc

Here are three great stocks positioned to outperform for patient investors.

Have $600 and 10 Years to Wait? Park It in These 3 Top Stocks

One pharmacy chain stands out because of its diversification.

Here's the Best Pharmacy Stock to Buy With a COVID Connection

Bio-Rad Laboratories

Horizon Pharma

Moderna

Insulet

QuidelOrtho Corp

Acceleron Pharma

Health Care Select Sector SPDR Fund

These are the healthcare stocks with the best value, fastest growth, and most momentum for January 2021.

Top Healthcare Stocks for January 2021

WOONSOCKET, R.I., Dec. 21, 2020 /PRNewswire/ -- CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the applicable Reference Yields and Total Consideration (each as summarized in the table below) to be paid in connection with the previously announced cash tender offers (each,...

CVS Health Corporation Announces Pricing of Tender Offers

CVS Health Corp. said Monday that it will begin COVID-19 vaccinations at long-term health facilities in Connecticut, Florida, Kentucky, Maine, Maryland, Nevada, New Hampshire, New York, Ohio, Oklahoma, Oregon, and Vermont this week. On Dec. 28, 36 more states and the District of Columbia will follow.

CVS Health will begin administering COVID-19 vaccinations at long-term health facilities this week

WOONSOCKET, R.I., Dec. 21, 2020 /PRNewswire/ -- CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the early results of the previously announced cash tender offers (each, a "Tender Offer" and collectively, the "Tender Offers") and that it is amending the Tender Offers by...

CVS Health Corporation Announces Early Results and Upsize of Previously Announced Cash Tender Offers to an Aggregate Principal Amount of $4,500,000,000 from $4,000,000,000 of Certain Outstanding Notes

CVS exhibits a consumer defensive business with strong competitive advantages. CVS is in great financial shape, growth prospects remain encouraging, and the stock is significantly undervalued.

CVS: Crushing The Market One Stock At A Time

Walgreens

Nursing home and assisted living facility residents are among the first to get the shots because they have been particularly hard-hit by the coronavirus.

CVS Health, Walgreens start providing Covid vaccines at thousands of hard-hit nursing homes

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other operating entities of Aetna Inc. (Aetna) that are now wholly owned subsidiaries of CVS Health Corporation (CVS Health) [NYSE: CVS]. These entities include the members of Aetna Health & Life Group. Concurrently, AM Best has affirmed the FSR of A- (Excellent)

News for CVS Health Stock (CVS)